ATE444739T1 - Polymerzusammensetzung sowie diese enthaltende darreichungsformen - Google Patents

Polymerzusammensetzung sowie diese enthaltende darreichungsformen

Info

Publication number: ATE444739T1
Authority: AT; Austria
Prior art keywords: dosage forms; polymer composition; forms containing; containing same; dosage form
Prior art date: 2002-09-28

Application number

AT03714356T

Other languages

English (en)

Inventor

Jen-Chi Chen

Frank Bunick

Harry Sowden

Original Assignee

Mcneil Ppc Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-09-28

Filing date

2003-03-21

Publication date

2009-10-15

2002-09-28 Priority claimed from PCT/US2002/031163 external-priority patent/WO2003026627A1/en

2003-03-21 Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc

2003-03-21 Priority claimed from PCT/US2003/008960 external-priority patent/WO2004028514A1/en

2009-10-15 Application granted granted Critical

2009-10-15 Publication of ATE444739T1 publication Critical patent/ATE444739T1/de

Links

AT03714356T 2002-09-28 2003-03-21 Polymerzusammensetzung sowie diese enthaltende darreichungsformen ATE444739T1 (de)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
PCT/US2002/031163 WO2003026627A1 (en)	2001-09-28	2002-09-28	Composite dosage forms
PCT/US2002/031129 WO2003026630A1 (en)	2001-09-28	2002-09-28	Dosage forms having an inner core and outer shell with different shapes
PCT/US2002/031062 WO2003026626A2 (en)	2001-09-28	2002-09-28	Modified release dosage forms
PCT/US2002/031117 WO2003026629A2 (en)	2001-09-28	2002-09-28	Modified release dosage forms
PCT/US2002/031024 WO2003026625A1 (en)	2001-09-28	2002-09-28	Modified release dosage forms
PCT/US2003/008960 WO2004028514A1 (en)	2002-09-28	2003-03-21	Polymer composition and dosage forms comprising the same

Publications (1)

Publication Number	Publication Date
ATE444739T1 true ATE444739T1 (de)	2009-10-15

Family

ID=34271652

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03714356T ATE444739T1 (de)	2002-09-28	2003-03-21	Polymerzusammensetzung sowie diese enthaltende darreichungsformen

Country Status (8)

Country	Link
JP (3)	JP2006517183A (de)
CN (3)	CN1700907A (de)
AT (1)	ATE444739T1 (de)
AU (4)	AU2003225944A1 (de)
BR (5)	BR0314804A (de)
CA (3)	CA2500312A1 (de)
DE (2)	DE60329614D1 (de)
MX (1)	MXPA05003283A (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2470463C (en)	2004-06-09	2012-09-18	Lornamead Brands, Inc.	Tooth whitening products and methods of making the same
SA07280459B1 (ar) *	2006-08-25	2011-07-20	بيورديو فارما إل. بي.	أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
EP2299986A1 (de) *	2008-06-19	2011-03-30	University Of The Witwatersrand, Johannesburg	Chronotherapeutische pharmazeutische dosierform
US20130011449A1 (en) *	2010-03-23	2013-01-10	Shiori Tomioka	Solid preparation
WO2013009701A2 (en) *	2011-07-08	2013-01-17	The University Of North Carolina At Chapel Hill	Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
EP2811985B1 (de) *	2012-02-07	2018-10-17	Johnson & Johnson Consumer Inc.	Schnell zerfallende filmtabletten
EP2857006A4 (de) *	2012-06-05	2015-12-30	Takeda Pharmaceutical	Trockenbeschichtete tablette
CA2959186C (en) *	2014-09-19	2020-03-24	The Procter & Gamble Company	Pulsed release phenylephrine dosage forms
KR20200111705A (ko) *	2017-12-29	2020-09-29	락손 메디칼 아게	약물 전달 시스템
CN116801868A (zh) *	2021-07-30	2023-09-22	埃维西亚治疗公司	5-羟色氨酸胃滞留剂型
CN115295864B (zh) *	2021-11-09	2023-08-11	深圳市德方创域新能源科技有限公司	正极补锂添加剂及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1994007470A1 (en) *	1992-09-30	1994-04-14	Pfizer Inc.	Article containing a core and a coating having a non constant thickness
GB9402203D0 (en) *	1994-02-04	1994-03-30	Smithkline Beecham Plc	Pharmaceutical formulation
DE4431653C2 (de) *	1994-09-06	2000-01-20	Lohmann Therapie Syst Lts	Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung
IT1282576B1 (it) *	1996-02-06	1998-03-31	Jagotec Ag	Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
US6602521B1 (en) *	1998-09-29	2003-08-05	Impax Pharmaceuticals, Inc.	Multiplex drug delivery system suitable for oral administration
JPWO2001078681A1 (ja) *	2000-04-17	2004-01-08	山之内製薬株式会社	薬物動態学的な薬物相互作用を回避する薬物送達システム及びその方法
EP1368006B1 (de) *	2001-02-13	2006-05-03	AstraZeneca AB	Neue formulierung mit modifizierter freisetzung

2003
- 2003-03-21 JP JP2004539770A patent/JP2006517183A/ja active Pending
- 2003-03-21 JP JP2004539769A patent/JP2006517182A/ja active Pending
- 2003-03-21 BR BR0314804-1A patent/BR0314804A/pt not_active Application Discontinuation
- 2003-03-21 BR BR0314547-6A patent/BR0314547A/pt not_active Application Discontinuation
- 2003-03-21 MX MXPA05003283A patent/MXPA05003283A/es unknown
- 2003-03-21 CN CN03825324.0A patent/CN1700907A/zh active Pending
- 2003-03-21 AU AU2003225944A patent/AU2003225944A1/en not_active Abandoned
- 2003-03-21 AU AU2003218359A patent/AU2003218359A1/en not_active Abandoned
- 2003-03-21 BR BR0314777-0A patent/BR0314777A/pt not_active Application Discontinuation
- 2003-03-21 BR BR0314787-8A patent/BR0314787A/pt not_active IP Right Cessation
- 2003-03-21 CA CA002500312A patent/CA2500312A1/en not_active Abandoned
- 2003-03-21 AT AT03714356T patent/ATE444739T1/de not_active IP Right Cessation
- 2003-03-21 CN CN03823065.8A patent/CN1684671A/zh active Pending
- 2003-03-21 CA CA002500311A patent/CA2500311A1/en not_active Abandoned
- 2003-03-21 AU AU2003220466A patent/AU2003220466A1/en not_active Abandoned
- 2003-03-21 JP JP2004539767A patent/JP2006517514A/ja active Pending
- 2003-03-21 AU AU2003220472A patent/AU2003220472A1/en not_active Abandoned
- 2003-03-21 DE DE60329614T patent/DE60329614D1/de not_active Expired - Lifetime
- 2003-03-21 DE DE60335270T patent/DE60335270D1/de not_active Expired - Lifetime
- 2003-03-21 CN CN03825331.3A patent/CN1700908A/zh active Pending
- 2003-03-21 CA CA2500313A patent/CA2500313C/en not_active Expired - Fee Related
- 2003-03-21 BR BR0314781-9A patent/BR0314781A/pt not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA2500311A1 (en)	2004-04-08
CA2500312A1 (en)	2004-04-08
AU2003218359A1 (en)	2004-04-19
MXPA05003283A (es)	2005-11-23
BR0314547A (pt)	2005-08-09
BR0314804A (pt)	2005-08-02
BR0314787A (pt)	2005-07-26
AU2003220466A1 (en)	2004-04-19
CN1700907A (zh)	2005-11-23
CN1700908A (zh)	2005-11-23
BR0314777A (pt)	2005-07-26
DE60335270D1 (de)	2011-01-20
DE60329614D1 (de)	2009-11-19
AU2003220472A1 (en)	2004-04-19
CA2500313C (en)	2011-06-07
CN1684671A (zh)	2005-10-19
JP2006517182A (ja)	2006-07-20
JP2006517183A (ja)	2006-07-20
JP2006517514A (ja)	2006-07-27
AU2003225944A1 (en)	2004-04-19
CA2500313A1 (en)	2004-04-08
BR0314781A (pt)	2005-07-26

Similar Documents

Publication	Publication Date	Title
ATE355829T1 (de)	2007-03-15	Einen lipophilen wirkstoff enthaltende feste pharmazeutische zusammensetzung sowie deren herstellung
BRPI0500704A (pt)	2006-04-04	composições de tratamento pessoal reidratáveis
ATE387191T1 (de)	2008-03-15	Kaubare weichkapsel
ATE288256T1 (de)	2005-02-15	Dermale zusammensetzungen
BR0113663A (pt)	2004-01-06	Composições de pelìcula de pectina
MXPA05001061A (es)	2005-10-05	Composiciones farmaceuticas, acuosas de 2,6-diisopropilfenol.
BR0214279A (pt)	2005-12-20	Composições farmacêuticas em forma particulada
MX2007008141A (es)	2007-12-10	Composicion farmaceutica de sustancias labiles en medio acido.
ATE444739T1 (de)	2009-10-15	Polymerzusammensetzung sowie diese enthaltende darreichungsformen
CY1109962T1 (el)	2014-09-10	Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
BR0007589A (pt)	2002-10-15	Inibidores da proliferação de células
NO20052575L (no)	2005-05-27	Nye forbindelser, deres fremstilling og anvendelse
ATE438385T1 (de)	2009-08-15	Pharmazeutische zusammensetzung
SE0302573D0 (sv)	2003-09-26	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
NO20050247L (no)	2005-03-16	Lavmolekylaert oversulfatert polysakkarid
ATE478662T1 (de)	2010-09-15	Arzneilösungen enthaltend modafinilverbindungen
MXPA05013390A (es)	2006-03-09	Composicion para el cuidado de la piel que comprende un agente aclarador de la piel.
WO2003066597A3 (en)	2004-04-01	Guanidino compounds
SE0302570D0 (sv)	2003-09-26	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
DE60208528D1 (de)	2006-03-30	Hochsulfatierte derivate von k5-polysacchariden und ihre herstellung
SE0302572D0 (sv)	2003-09-26	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
DK1735005T3 (da)	2012-05-29	Fremgangsmåde til indkapsling af oralt indtagne materialer til ændring af fordøjelsesstedet, virkningsstedet eller stabiliteten
DE60103619D1 (de)	2004-07-08	Pharmazeutische zubereitungen enthaltend alginate
DE60206940D1 (de)	2005-12-01	Pektin und ascorbinsäure enthaltende zusammensetzungen
ATE353639T1 (de)	2007-03-15	In-vitro-verwendung von astaxanthin zur vorbehandlung von zellen vor uv-bestrahlung zwecks hemmung der aktivierung von nf-kb

Legal Events

Date	Code	Title	Description
2010-04-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties